Chewable vs Topical vs Pills: Comparing Flea and Tick Medicine for Dogs

Two formats cover nearly every dog in the United States: something the dog swallows, and something you squeeze onto the skin between the shoulder blades. Both work. Both carry real limits tied to your dog’s weight, age, and health history, and the FDA’s guidance is blunt that the label on the box you’re holding is the only authority worth trusting.

Here’s what actually separates them, and where the choice gets made for you.

Chewable vs Topical vs Pills: What The Three Words Really Mean

The three terms collapse into two categories, because “pills” in flea-and-tick talk means oral tablets or chews — the FDA groups these approved drugs as oral tablets and chewable tablets, not as a separate pill class.

Oral products are swallowed and absorbed into the bloodstream. Topicals are applied to the skin and spread across the coat. The naming difference matters less than the dosing schedule behind it, which is where the products genuinely diverge.

• Chewables and tablets (oral): Bravecto Chews, NexGard, Simparica, Credelio, and Simparica Trio.
• Topicals: Bravecto topical solution for dogs, plus prescription options such as Frontline and K9 Advantix II.
• Collars: a third format entirely — Seresto is an 8-month collar, outside the chewable/topical/pill comparison.

How Often Each One Gets Given

Dosing interval is the most visible difference, and the spread is wide — from one month to nearly a year.

NexGard covers fleas and ticks for one month in dogs 8 weeks and older and at least 4 lb. Bravecto Chews runs 12 weeks for fleas and most ticks, though lone star tick coverage lasts 8 weeks; it’s labeled for puppies 6 months and up, 4.4 lb or more. Bravecto 1-Month is a shorter version for puppies 8 weeks and older.

Cornell’s flea-and-tick table lists K9 Advantix II and Vectra 3D as monthly topicals. Frontline appears there as a monthly topical without tick-attachment prevention — a distinction worth knowing if ticks are your main problem.

Safety, Species, and the Seizure Question

Format doesn’t determine safety — the individual drug does, and one caution applies across the isoxazoline family.

The FDA notes that isoxazoline products have been associated with neurologic adverse events, and Cornell specifically flags that chewables containing isoxazoline have been linked to a rare occurrence of seizures. That doesn’t make them unsafe for most dogs, but it’s the reason the FDA tells owners to check with a veterinarian if the dog has a history of seizures or neurologic issues, or if a reaction occurs after dosing.

The FDA’s safe-use guidance comes down to three checks before anything goes in the dog or on the skin: read the label every time (directions and warnings can change), confirm the product is labeled for your pet’s life stage, and confirm the dog meets the minimum weight.

The mistake that causes real harm is cross-species assumption. The FDA separation of dog and cat products exists for a reason — a dog product is not automatically safe for a cat, and some flea-and-tick ingredients are outright dangerous to cats.

If you want the tested shortlist instead of the theory, our breakdown of the best dog flea and tick medicine puts the formats side by side with what actually held up.

The Choice Usually Makes Itself

Format matters far less than fit. A dog that spits out chews or has skin sensitivities pushes you toward the other option, and a dog under the minimum weight pushes you off certain products entirely.

Cornell’s table makes the bravecto split concrete: the same brand exists as a chew and as a topical, with monthly or 3-month versions depending on formulation — so brand loyalty doesn’t decide your format, the label does.

For the dog whose weight, age, and health clear the label, chews and topicals both do the job. Read the box, check the minimums, and ask your vet about anything neurologic in the dog’s history. The FDA’s isoxazoline adverse-event fact sheet is the page worth opening before you buy.